
Eli Lilly Strengthens Market Position With Weight-Loss Drug Success
Eli Lilly strengthens market position with blockbuster weight-loss drug Zepbound, diversified pipeline, and AI integration, supporting consistent financial performance and shareholder returns.
LLYdividend growthweight loss drugs